14 Recruiting Studies at University Of Wisconsin Carbone Cancer Center
Active clinical trials at this research center, sourced directly from the NIH registry.
π Madison, Wisconsin
All research centersRecruiting Studies at University Of Wisconsin Carbone Cancer Center
π΅ Active, Not Recruiting Phase1 / Phase2 π Investigational Drug / Biologic
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
Prostate Cancer
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer
Prostate Cancer
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
Split-Dose R-CHOP for Older Adults With DLBCL
Diffuse Large B Cell Lymphoma
View Study & Checklist β π΅ Active, Not Recruiting Phase2 π Investigational Drug / Biologic
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
Metastatic Colorectal Cancer
View Study & Checklist β π΅ Active, Not Recruiting Early Phase1 π Investigational Drug / Biologic
Pilot Study of Imatinib Cetuximab Combo for H & N Cancer
Head and Neck Cancer
View Study & Checklist β π΅ Active, Not Recruiting Phase1 π Investigational Drug / Biologic
Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy
Head and Neck Cancer
View Study & Checklist β π‘ Not Yet Recruiting Phase2 π Investigational Drug / Biologic
Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast Cancer
HR+/HER2+ Breast Cancer
View Study & Checklist β NOT_YET_RECRUITING Early Phase1 π Investigational Drug / Biologic
Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy
Metastatic Castration-resistant Prostate Cancer
View Study & Checklist β π’ Recruiting Phase2 π Investigational Drug / Biologic
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
Esophageal Adenocarcinoma
View Study & Checklist β π’ Recruiting Phase2 π Clinical Research Protocol
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer
Breast Cancer
View Study & Checklist β π’ Recruiting Early Phase1 π Investigational Drug / Biologic
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
ERΞ±+ Breast Cancer
View Study & Checklist β π’ Recruiting Phase2 π Investigational Drug / Biologic
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
View Study & Checklist β π’ Recruiting Phase1 π Investigational Drug / Biologic
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Acute Myeloid Leukemia
View Study & Checklist β π’ Recruiting Interventional Protocol π Observational Clinical Research
UWCCC Molecular Tumor Board Registry
Hematologic Neoplasms
View Study & Checklist β